Actinium-225 (Ac-225)

  • Dry Nitrate
  • We’re offering on site labelling service for magistral (gallenic) production applications.
  • Labelling services in your center would be finalized with our Alpha Probe TLC analysis to let you be safely release to use the final product on your patients.

Actinium-225 (Ac-225) is an isotope of actinium. It decays to Francium-221 through alpha decay with a half-life of    10 days and is an intermediate decay product in the Neptunium series (the decay chain that starts with Np-237). Although it is found in nature in very small amounts due to this decay chain, Ac-225 is entirely synthetic.

The decay properties of Actinium-225 make it suitable for use in targeted alpha therapy (TAT). Clinical trials have demonstrated the applicability of radiopharmaceuticals containing Ac-225 in treating various types of cancer.

Ac-225-labeled compounds are used to target various cancer types, including prostate cancer, neuroendocrine tumors, breast cancer, and leukemia.

We're ready to collaborate!

You can contact us to learn more about our products and solutions and to get acquainted.